title: Neutralizing the MERS coronavirus threat.
abstract: Human neutralizing monoclonal antibodies are candidates for prophylactic and therapeutic interventions against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
authors.affiliation: Department of Viroscience, Erasmus Medical Center, 3000 CA Rotterdam, the Netherlands.
authors.forename: Bart L
authors.initials: BL
authors.lastname: Haagmans
authors.forename: Albert D M E
authors.initials: AD
authors.lastname: Osterhaus
mesh_terms: D057134:Antibodies, Neutralizing / Q000276:immunology*; D018352:Coronavirus Infections / Q000517:prevention & control* / Q000821:virology; D006801:Humans; D065207:Middle East Respiratory Syndrome Coronavirus / Q000276:immunology / Q000472:pathogenicity*
chemical_list: D057134:Antibodies, Neutralizing